Amy West, Head of US Digital Health & Innovation Strategy at Novo Nordisk, joined the show in April 2023 during the early days of the semaglutide rush to share how human-centered clinical approaches are innovating digital therapeutics and patient treatments.
What do you think?
This show is produced by the Consumer-First Health Group, the community for consumer health enthusiasts. (#393)